UCB 
By UCB is a global biopharma focused on severe diseases with operations in more than 40 countries and global revenue of €3.6 billion in 2008.
We combine biology and chemistry to make major
breakthroughs. By integrating our expertise in large,
antibody-based molecules and small, chemically-derived
molecules, we can offer families with severe diseases and
their specialist physicians the advantages of both large
and small molecules to produce extraordinary
breakthroughs.
We partner with the leaders in the pharmaceutical industry.
The complexities of severe diseases are beyond the
expertise and resources of a single organisation. That is
why we have teamed up with partners - we play to our
strengths and tap into the organisations with greater or
complementary strengths.
| distribué par | Ce noodl a été diffusé par UCB SA et initialement mise en ligne sur le site http://www.ucb-group.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-23 12:59:22 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
